One of the major challenges facing the targeted drug delivery market is the extremely high costs associated with research and development. Developing new targeted drug delivery systems requires extensive pre-clinical testing as well as multiple phases of clinical trials to evaluate safety and efficacy. This drug development process takes many years and costs pharmaceutical companies hundreds of millions of dollars. For example, according to data from the U.S. Food and Drug Administration, the average out-of-pocket cost to develop a new prescription drug was estimated to be over US$ 2.60 billion in 2021. Considering the financial risks, many companies are hesitant to invest such vast amounts in innovative but unproven targeted drug delivery technologies.
Market Opportunities: Expanding Healthcare Infrastructure in Developing Nations
Expanding healthcare infrastructure in developing nations presents a great opportunity for targeted drug delivery market. As developing countries are increasingly investing in public healthcare systems to provide universal access to medical care, it allows for innovative drug delivery technologies to reach remote populations at scale.
Targeted Drug Delivery Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients